Source: Annual Congress 2007 - New drugs for COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Stolk, R. A. Stockley, A. Rames, O. Rutman, S. Soliman (RC Leiden, Netherlands; Birmingham, United Kingdom; Basel, Switzerland). REPAIR II: retinoid treatment of emphysema patients on the alpha-1-antitrypsin international registry. Eur Respir J 2007; 30: Suppl. 51, 1293

Member's Comments

No comment yet.

Related content which might interest you: Functional decline over time in patients with IPF treated with pirfenidone: the PROOF registry Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Prospective observational study in patients with obstructive lung disease: NOVELTY design Source: ERJ Open Res, 5 (1) 00036-2018; 10.1183/23120541.00036-2018 Year: 2019 Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Evaluation of roflumilast in COPD patients in a real-world European setting: results from the PROFILE EU study Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study) Source: Eur Respir J, 57 (2) 2002718; 10.1183/13993003.02718-2020 Year: 2021 Genotyping and phenotyping of alpha1-antitrypsin deficiency Greek patients under augmentation therapy: a multicenter study Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 CompERA-XL: International, prospective registry for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Health and functional status of tiotropium/olodaterol-treated patients with COPD: results from the AERIAL® non-interventional study Source: ERJ Open Res, 7 (3) 00004-2021; 10.1183/23120541.00004-2021 Year: 2021 Incidence of multiple progression events in patients with idiopathic pulmonary fibrosis (IPF) in the pooled CAPACITY and ASCEND trials Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights Year: 2017 Assessment of costs and outcomes of chemotherapy in an observational setting in patients with advanced NSCLC (ACTION) Source: Eur Respir J 2004; 24: Suppl. 48, 304s Year: 2004 Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry Source: Eur Respir J 2015; 46: 186-196 Year: 2015 TOPP: the first international registry in pediatric pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 The national alpha-1 antitrypsin deficiency registry in Poland Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Alpha-1 antitrypsin deficiency in patients with bronchiectasis: data from the European Bronchiectasis Registry EMBARC Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Randomised controlled trial for emphysema with a selective agonist of the ?-type retinoic acid receptor Source: Eur Respir J 2012; 40: 306-312 Year: 2012 Pulmonary embolism in the multicentre advanced study for a thromboembolism registry (MASTER): study design and patients recruited Source: Eur Respir J 2005; 26: Suppl. 49, 595s Year: 2005 Protocol for the EARCO Registry: a pan-European observational study in patients with a1-antitrypsin deficiency Source: ERJ Open Res, 6 (1) 00181-2019; 10.1183/23120541.00181-2019 Year: 2020